Messing, VMD, PhD, A. An in Vivo Pharmacological Screen Identifies Cholinergic Signaling As a Therapeutic Target in Glial-Based Nervous System Disease.
Wang L, Hagemann TL, Messing A, Feany MB (2016). An in vivo pharmacological screen identifies cholinergic signaling as a therapeutic target in glial-based nervous system disease. Journal of Neuroscience, 36, 1445-1455